FdaApplication
ANDA 216096
Identifiers
- fda_app_no: ANDA216096
Properties
| Property | Value |
|---|---|
| applicant_name | DEXCEL PHARMA TECHNOLOGIES LTD |
| application_type | ANDA |
| approval_date | 2022-05-24 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OMEPRAZOLE MAGNESIUM | OMEPRAZOLE MAGNESIUM | EQ 20MG BASE | CAPSULE, DELAYED RELEASE;ORAL |
1 product